Overview of glucagon-like peptide-1 and its role in glucose metabolism New-generation antidiabetic agents, particularly those targeting the glucagon-like peptide-1 (GLP-1) pathway, represent a significant advancement in the treatment of type 2 diabetes
certain antifungals such as fluconazole (Diflucan), griseofulvin (Grifulvin, Gris-PEG), itraconazole (Onmel, Sporanox), ketoconazole (Extina, Ketozole, Nizoral, Xolegel), and voriconazole (Vfend)
Body Bias Is Affecting Careers If GLP-1-induced weight loss made people healthier, happier, more productive, or more motivated, we might expect women already working to experience career improvements as well
The gut microbiome coexists with human cells in the intestines and produces by-products that are crucial for health
Those with certain health conditions may also need extra monitoring